Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orifarm Manufacturing Hobro A/S
A/S
Active
CVR 41059044
Apotekerstien 9, 9500
Hobro
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2020
64 employees
www.orifarm.com
Watchlist
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Orifarm Manufacturing Hobro A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MF
Mads Fink Eriksen
Chief Executive Officer
Chief Executive Officer
2026
Former (6)
AD
Allan Dinesen
Chief Executive Officer
Chief Executive Officer
2021 – 2021
TH
Thomas Hørslev Hedegaard
Chief Executive Officer
Chief Executive Officer
2024 – 2026
JL
Jacob Lucassen
Chief Executive Officer
Chief Executive Officer
2021 – 2024
PA
Peter Andreas Stakemann
Management
Management
2020 – 2020
GA
Ghita Astrup
Management
Management
2020 – 2021
MD
Marianne Damgaard-Sørensen
Management
Management
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HC
Hans Carl Bøgh-Sørensen
Chairman
2025
NL
Nicki Lund Kristensen
Board of Directors
2025
Former (1)
ES
Erik Sandberg
Chairman
2021 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ORIFARM GROUP A/S
Company
100%
100%
2021
Takeda Pharmaceuticals International AG
Individual
100%
100%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orifarm Manufacturing Hobro A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network